» Articles » PMID: 37176044

and Enteroviruses As Synergistic Triggers of Type 1 Diabetes Mellitus

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 May 13
PMID 37176044
Authors
Affiliations
Soon will be listed here.
Abstract

What triggers type 1 diabetes mellitus (T1DM)? One common assumption is that triggers are individual microbes that mimic autoantibody targets such as insulin (INS). However, most microbes highly associated with T1DM pathogenesis, such as coxsackieviruses (COX), lack INS mimicry and have failed to induce T1DM in animal models. Using proteomic similarity search techniques, we found that COX actually mimicked the INS receptor (INSR). were the best mimics of INS. antibodies cross-reacted with INS in ELISA experiments, confirming mimicry. COX antibodies cross-reacted with INSR. antibodies further bound to COX antibodies as idiotype-anti-idiotype pairs conserving INS-INSR complementarity. Ultraviolet spectrometry studies demonstrated that INS-like peptides bound to INSR-like COX peptides. These complementary peptides were also recognized as antigens by T cell receptor sequences derived from T1DM patients. Finally, most sera from T1DM patients bound strongly to inactivated , while most sera from healthy individuals did not; T1DM sera also exhibited evidence of anti-idiotype antibodies against idiotypic INS, glutamic acid decarboxylase, and protein tyrosine phosphatase non-receptor (islet antigen-2) antibodies. These results suggest that T1DM is triggered by combined enterovirus- (and possibly combined Epstein-Barr-virus-) infections, and the probable rate of such co-infections approximates the rate of new T1DM diagnoses.

Citing Articles

T-Cell Receptor Sequences Identify Combined Coxsackievirus- Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus- Infections for Type 1 Diabetes.

Root-Bernstein R Int J Mol Sci. 2024; 25(3).

PMID: 38339075 PMC: 10855694. DOI: 10.3390/ijms25031797.

References
1.
Gergely A, Koranyl L, Halmos T, Zsombok M, Peterfy F, Csizer F . Anti-glucagon antibodies in diabetes mellitus. Ann Immunol Hung. 1973; 17:231-3. View

2.
Buschard K . The etiology and pathogenesis of type 1 diabetes - A personal, non-systematic review of possible causes, and interventions. Front Endocrinol (Lausanne). 2022; 13:876470. PMC: 9452747. DOI: 10.3389/fendo.2022.876470. View

3.
Romero J . Pediatric group B coxsackievirus infections. Curr Top Microbiol Immunol. 2008; 323:223-39. DOI: 10.1007/978-3-540-75546-3_10. View

4.
Boettler T, von Herrath M . Protection against or triggering of Type 1 diabetes? Different roles for viral infections. Expert Rev Clin Immunol. 2010; 7(1):45-53. PMC: 3077770. DOI: 10.1586/eci.10.91. View

5.
Zhao M, Xu S, Cavagnaro M, Zhang W, Shi J . Quantitative Analysis and Visualization of the Interaction Between Intestinal Microbiota and Type 1 Diabetes in Children Based on Multi-Databases. Front Pediatr. 2022; 9:752250. PMC: 8715853. DOI: 10.3389/fped.2021.752250. View